Location: United States
Employees: 11-50
Total raised: $200M
Investors 1
| Date | Name | Website |
| - | Apple Tree... | appletreep... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 06.09.2025 | Series C | $100M | Janus Hend... |
| 15.09.2022 | Series B | $100M | - |
Mentions in press and media 13
| Date | Title | Description |
| 07.09.2025 | Galvanize Therapeutics Secures $100M: Revolutionizing Oncology and Chronic Lung Disease Treatment | Galvanize Therapeutics landed a significant $100 million Series C financing. This substantial capital propels its innovative pulsed electric field (PEF) therapies. The Redwood City firm targets critical unmet needs in oncology and chronic l... |
| 06.09.2025 | Galvanize Therapeutics: $100 Million Raised For Advancing Therapies For Cancer And Chronic Lung Disease | Galvanize Therapeutics, a commercial-stage medical technology company developing novel pulsed electric field therapies, has announced the successful close of a $100 million Series C financing round. The round was oversubscribed, reflecting ... |
| 04.09.2025 | Galvanize Therapeutics nets $100M, and a new CEO, to bring pulsed field ablation to lung cancer | Galvanize Therapeutics has raised $100 million in venture capital backing—and is making a change in leadership—to help energize its development of pulsed field ablation technology for use against cancer and respiratory conditions. The compa... |
| 03.09.2025 | Galvanize Therapeutics Raises $100M in Series C Financing | Galvanize Therapeutics, Redwood City, CA-based commercial-stage medical technology company advancing pulsed electric field (PEF) therapies for oncology and chronic lung disease, raised a $100m Series C financing. The round was led by Sofinn... |
| 20.05.2025 | New Study Published on the Safety and Feasibility of Pulsed Electric Field Ablation for Early-Stage Non-Small Cell Lung Cancer Prior to Surgical Resection | Innovative technology offers promising non-thermal approach to soft tissue ablation without compromising sensitive structures. REDWOOD CITY, Calif., May 20, 2025 /PRNewswire/ -- A new publication featuring Aliya® PEF has been published in t... |
| 06.08.2024 | Galvanize Therapeutics Completes Enrollment in Clinical Trial Evaluating Aliya® Pulsed Electric Field (PEF) System for Late-Stage Non-Small Cell Lung Cancer and Metastasis to the Lung | REDWOOD CITY, Calif., Aug. 6, 2024 /PRNewswire/ -- Galvanize Therapeutics, Inc., a leader in developing pulsed electric field therapies for chronic bronchitis and solid tumors, has completed enrollment in the AFFINITY study evaluating Aliya... |
| 02.07.2024 | Galvanize Appoints Executive Chairman and New Oncology-Focused Director to the Board of Directors | Doug Godshall Becomes Executive Chairman Zhen Su, MD, MBA, Appointed to the Board of Directors to Bring Oncology Expertise REDWOOD CITY, Calif., July 2, 2024 /PRNewswire/ -- Galvanize, a leader in Pulsed Electric Field (PEF) technologies, t... |
| 28.05.2024 | Galvanize Receives FDA Clearance for the INUMI Flex Endoscopic Needle, Expanding its Aliya® Pulsed Electric Field (PEF) Portfolio for Soft Tissue Ablation | First Commercially Available Endoscopic Pulsed Electric Field Ablation System for Soft Tissue Lesions REDWOOD CITY, Calif., May 28, 2024 /PRNewswire/ -- Galvanize today announced that it received U.S. Food and Drug Administration 510(k) reg... |
| 15.09.2022 | Galvanize Therapeutics Pulls In $100M Series B | SAN CARLOS, CA, Galvanize Therapeutics today announced it has completed a $100 million Series B funding round. >> Click here for more funding data on Galvanize Therapeutics >> To export Galvanize Therapeutics funding data to... |
| 15.09.2022 | Galvanize Therapeutics Announces Merger to Create the Premier Pulsed Electric Field Therapy Company and Completion of $100 Million Series B Financing | Merger unites three companies created by life sciences venture capital firm ATP—Gala Therapeutics, Galaxy Medical, and Galvanize Therapeutics—to create a single company based on the AliyaTM Pulsed Electric Field (PEF) energy platform |
Show more